Kratzsch T - Search Results

1

Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.

Alcaniz J, Winkler L, Dahlmann M, Becker M, Orthmann A, Haybaeck J, Krassnig S, Skofler C, Kratzsch T, Kuhn SA, Jödicke A, Linnebacher M, Fichtner I, Walther W, Hoffmann J. Alcaniz J, et al. Among authors: kratzsch t. Front Oncol. 2023 Apr 11;13:1129627. doi: 10.3389/fonc.2023.1129627. eCollection 2023. Front Oncol. 2023. PMID: 37114125 Free PMC article.

2

Role of mTOR and VEGFR Inhibition in Prevention of Metastatic Tumor Growth in the Spine.

Kratzsch T, Piffko A, Broggini T, Czabanka M, Vajkoczy P. Kratzsch T, et al. Front Oncol. 2020 Feb 19;10:174. doi: 10.3389/fonc.2020.00174. eCollection 2020. Front Oncol. 2020. PMID: 32140451 Free PMC article.

3

Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.

Kratzsch T, Kuhn SA, Joedicke A, Hanisch UK, Vajkoczy P, Hoffmann J, Fichtner I. Kratzsch T, et al. J Cancer Res Clin Oncol. 2018 May;144(5):809-819. doi: 10.1007/s00432-018-2600-1. Epub 2018 Feb 9. J Cancer Res Clin Oncol. 2018. PMID: 29427211

4

Catheter-tip Granulomas Associated with Intrathecal Drug Delivery--A Two-Center Experience Identifying 13 Cases.

Kratzsch T, Stienen MN, Reck T, Hildebrandt G, Hoederath P. Kratzsch T, et al. Pain Physician. 2015 Sep-Oct;18(5):E831-40. Pain Physician. 2015. PMID: 26431137 Free article.

5

[Low-grade gliomas in adults].

Kratzsch T, Gautschi OP, Kuhn SA, Hottinger AF, Hildebrandt G, Stienen MN. Kratzsch T, et al. Praxis (Bern 1994). 2014 Nov 12;103(23):1385-96. doi: 10.1024/1661-8157/a001835. Praxis (Bern 1994). 2014. PMID: 25391745 Review. German.

6

Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.

Kuhn SA, Martin M, Brodhun M, Kratzsch T, Hanisch UK, Haberl H. Kuhn SA, et al. Among authors: kratzsch t. Neurol Res. 2014 Aug;36(8):709-21. doi: 10.1179/1743132813Y.0000000303. Epub 2014 Jan 29. Neurol Res. 2014. PMID: 24620969

7

Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.

Pilatus U, Lais C, Rochmont Adu M, Kratzsch T, Frölich L, Maurer K, Zanella FE, Lanfermann H, Pantel J. Pilatus U, et al. Among authors: kratzsch t. Psychiatry Res. 2009 Jul 15;173(1):1-7. doi: 10.1016/j.pscychresns.2008.07.015. Epub 2009 May 9. Psychiatry Res. 2009. PMID: 19427767

8

Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's disease.

Frey C, Bonert A, Kratzsch T, Rexroth G, Rösch W, Müller-Spahn F, Maurer K, Müller WE, Eckert A. Frey C, et al. Among authors: kratzsch t. J Neural Transm (Vienna). 2006 Nov;113(11):1753-61. doi: 10.1007/s00702-006-0481-y. Epub 2006 Jun 1. J Neural Transm (Vienna). 2006. PMID: 16736246

9

Enhanced ROS-generation in lymphocytes from Alzheimer's patients.

Leutner S, Schindowski K, Frölich L, Maurer K, Kratzsch T, Eckert A, Müller WE. Leutner S, et al. Among authors: kratzsch t. Pharmacopsychiatry. 2005 Nov;38(6):312-5. doi: 10.1055/s-2005-916186. Pharmacopsychiatry. 2005. PMID: 16342003

10

[The health policy of the "Council of the People's Representatives": the German revolution 1918/1919 in medical historical perspective II: health policy as a factor of continuity and stability].

Kratzsch T. Kratzsch T. Medizinhist J. 2005;40(1):19-49. Medizinhist J. 2005. PMID: 16106789 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters